osteoporosis

Good news for people with osteoporosis

sailajabyrisetty's picture
Submitted by sailajabyrisetty on Sat, 11/03/2007 - 22:22.
in

A monthly two-day dosing regimen approved for Canadians…. Health Canada recently approved risedronate (ACTONEL) 75 mg, a monthly two-day dosing regimen for the treatment of postmenopausal osteoporosis for use in Canada. Patients take this new ACTONEL 75 mg tablet on two consecutive days each month.

Syndicate content